APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,064,165 | -84.2% | 54,263 | -62.2% | 0.01% | -83.9% |
| Q2 2023 | $13,063,922 | +199.0% | 143,402 | +116.5% | 0.06% | +181.8% |
| Q1 2023 | $4,368,861 | -40.5% | 66,235 | -38.4% | 0.02% | -45.0% |
| Q3 2022 | $7,339,000 | +96.7% | 107,452 | +46.3% | 0.04% | +90.5% |
| Q1 2022 | $3,731,000 | +3.6% | 73,426 | -3.6% | 0.02% | +5.0% |
| Q4 2021 | $3,601,000 | -68.7% | 76,162 | -78.2% | 0.02% | -73.0% |
| Q3 2021 | $11,493,000 | +17.5% | 348,708 | +125.3% | 0.07% | +8.8% |
| Q2 2021 | $9,783,000 | +2064.4% | 154,799 | +1859.2% | 0.07% | +1600.0% |
| Q4 2020 | $452,000 | -11.9% | 7,901 | -52.9% | 0.00% | -60.0% |
| Q4 2019 | $513,000 | +123.0% | 16,762 | +42.1% | 0.01% | +42.9% |
| Q1 2019 | $230,000 | – | 11,798 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |